Mycoplasma genitalium antimicrobial resistance in community and sexual health clinic patients, Auckland, New Zealand

Vesty, Anna; McAuliffe, Gary; Roberts, Sally; Henderson, Gillian; Basu, Indira

Mycoplasma genitalium antimicrobial resistance in community and sexual health clinic patients, Auckland, New Zealand

Files

19-0533.pdf (507.65 KB)

Authors

Vesty, Anna

McAuliffe, Gary

Roberts, Sally

Henderson, Gillian

Basu, Indira

Issue Date

2020-02

Type

Article

Language

en_US

Keywords

Mycoplasma Genitalium , Genotypic Antimicrobial Resistance , Quinolone Resistance–Determining Region , Sexually Transmitted Infections , Bacteria , Bacterial Infections , New Zealand , Antimicrobial Resistance

Abstract

Our retrospective study compared genotypic antimicrobial resistance in Mycoplasma genitalium–positive specimens collected from 48 community and 33 sexual health clinic (SHC) patients. Macrolide resistance was similar in community (75%) and SHC (76%) patients. We observed no significant difference in fluoroquinolone resistance between community (19%) and SHC (27%) patients (p = 0.66).

Citation

Vesty, A., McAuliffe, G., Roberts, S., Henderson, G., & Basu, I. (2020). Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand. Emerging infectious diseases, 26(2), 332–335. https://doi.org/10.3201/eid2602.190533

Publisher

Emerging Infectious Diseases